Insight的封面图片
Insight

Insight

医院和医疗保健

Scientific and Pharmaceutical AI Solutions Built on Real World Research Data.

关于我们

Insight offers innovative pharmaceutical AI intelligence solutions. Harnessing the most up to date insight on Compounds, Clinical trials, Disease profiles, Targets, Regulatory Intelligence and Company analysis. The Insight platform includes a wealth of information on drugs, including data on the safety and effectiveness of existing medications, as well as information on new and emerging drugs. Additionally, the platform includes detailed information on clinical trials, including data on current and ongoing trials. Finally, our platform includes comprehensive information on a wide range of diseases, including data on the latest treatments and therapies, as well as insights on disease prevalence and incidence rates.

网站
https://www.idm-insight.com/research
所属行业
医院和医疗保健
规模
11-50 人
总部
Boston
类型
私人持股
创立
2021
领域
healthcare、analytics、AI、pharmaceutical、clinical trials和protocols

产品

地点

Insight员工

动态

  • 查看Insight的组织主页

    2,586 位关注者

    Breaking: “We are thrilled to announce that Stefano Lagravinese, PhD, CEO of ClinOpsHub, has joined the Scientific Advisory Board of Insight” Stefano’s career in clinical research spans over two decades, from his early days as a Clinical Research Associate in ICON plc and Worldwide Clinical Trials to becoming a visionary entrepreneur and industry leader. As the founder and CEO of ClinOpsHub, he has built a company that not only conducts and optimises clinical trials but also plays a crucial role in training and shaping the next generation of clinical operations professionals. Through his initiatives, he has contributed to the evolution of the field, helping companies streamline their trial processes while mentoring future leaders in clinical research. At Insight, we are committed to revolutionizing clinical trials through cutting-edge technologies and science to improve efficiency, reduce costs, and accelerate drug development. Stefano’s unique blend of scientific expertise, business acumen, and educational leadership brings a strategic advantage to our mission. His deep understanding of both operational and commercial aspects of clinical trials will help us refine our solutions, ensuring they not only meet scientific and regulatory standards but also align with business needs and industry trends. Join us in welcoming Stefano Lagravinese to Insight #insight #clinOpsHub

  • 查看Insight的组织主页

    2,586 位关注者

    New "That’s a Load of Science” Episode: "Molecular Makeover: CRISPR Edition" ?? CRISPR isn’t just a buzzword—it’s a scientific revolution reshaping medicine, agriculture, and biotechnology. But how did we get here, and what’s next? In this episode of That's a Load of Science, we sit down with Ruben Vazquez-Uribe, a scientist working at the forefront of gene editing, to explore: ?? How CRISPR works – breaking down the molecular "scissors" that let scientists edit DNA with precision ??? The origins and evolution – from a bacterial defense mechanism to a tool that won the Nobel Prize ??? The ethical and regulatory landscape – where do we draw the line between innovation and ethical concerns? ??? Medical breakthroughs – how CRISPR is being used to fight genetic diseases, from sickle cell anemia to rare disorders ??? Beyond medicine – the role of gene editing in agriculture, sustainability, and even de-extinction efforts CRISPR is more than just a tool—it’s rewriting the future of science. But with its power to alter life’s blueprint, it also raises big questions. What should we change? And what should we leave untouched? ?? If you’re curious about gene editing, bioethics, and the future of biotechnology, this episode is a must-listen! What excites (or concerns) you most about CRISPR? Let’s discuss in the comments! ?? For more information on Ruben’s work, check his website:?? https://rvuribe.com/ And some of his relevant publications: https://lnkd.in/embrFVYz? https://lnkd.in/eDyQHKaM?

  • 查看Insight的组织主页

    2,586 位关注者

    That’s a Load of Science - Episode 10: The Rise of the Machines: And Drug ? AI and machine learning are reshaping drug discovery at an unprecedented pace. But how do these technologies move from theoretical promise to practical breakthroughs? What challenges exist between academia and industry, and how can collaboration drive progress? ? In this episode of "That’s a Load of Science", Alessio De Simone, PhD. sits down with our Scientific Board member Prof. Giovanni Bottegoni, a leading expert in computational chemistry and drug discovery, to discuss: ? ?? From Prediction to Validation: How machine learning is being used to not only predict potential drug candidates but also validate them in real-world applications. ??? Academia vs. Pharma: The differences in approach, the push toward open collaboration, and the bureaucratic roadblocks that slow innovation. ?? The Role of Molecular Dynamics & Deep Learning: Molecular Dynamics has been evolving for over 30 years—how is it being leveraged alongside deep learning to revolutionize drug discovery? ?? AI Regulation & the Future of Drug Development: What regulatory challenges exist for AI-driven drug discovery, and where is the field headed? ? We’re witnessing a transformative moment in science, where AI’s role in computational chemistry is changing the way we discover, test, and develop new drugs. But the key question remains: how do we effectively integrate these innovations while overcoming industry-wide hurdles? ? Join us as Alessio dives into these and other critical topics with Prof. Bottegoni and explore the future of AI in Pharma! ? ?? Listen now: YouTube: https://lnkd.in/eu-veFUK Spotify: https://lnkd.in/eidbvANQ ? To know more about Giovanni's research, visit: https://camd.uniurb.it #AIinPharma #DrugDiscovery #MachineLearning #PharmaInnovation #ComputationalChemistry

  • 查看Insight的组织主页

    2,586 位关注者

    We are proud to announce that Alessio De Simone, PhD, Chief Medical Officer at IDM Insight, has been reconfirmed for two more years as an Editorial Board Member of Current Topics in Medicinal Chemistry, a prestigious peer-reviewed journal at the forefront of pharmaceutical and medicinal chemistry research. This recognition underscores IDM Insight’s unwavering commitment to scientific excellence and validation. By actively shaping the discourse in medicinal chemistry, our leadership remains deeply embedded in the cutting edge of drug development, regulatory advancements, and clinical innovation. #IDMInsight #MedicinalChemistry #ScientificExcellence #DrugDevelopment #ClinicalInnovation #PharmaAI #ResearchExcellence #HealthcareInnovation #Biotech

  • Insight转发了

    查看Harvrinder Athwal的档案

    CEO at XSS Capital

    The landscape of clinical trials is evolving rapidly, with increasing demands for efficiency, cost-effectiveness, and inclusivity in research.? IDM Insight has developed "ClinCraft", in partnership with?Nvidia?and?AWS, to simplify the clinical trial protocol development process, enabling researchers to?leverage?advanced algorithms?and?data analytics. ClinCraft provides real-time insights and personalized recommendations?tailored?to specific research needs.? See buff.ly/4g8WJsv IDM Insight is a portfolio company of XSS Capital. DM me for more info and join us on the ground floor of what is going to be a spectacular journey.

    • 该图片无替代文字
  • 查看Insight的组织主页

    2,586 位关注者

    Clinical trials are crucial for medical advancements, but they often face challenges such as inefficiencies, high costs, and regulatory hurdles. ClinCraft, an AI-driven tool developed by IDM Insight, is transforming clinical trial protocol optimization by streamlining design, enhancing efficiency, and ensuring compliance. By leveraging a vast database of clinical trial records and regulatory requirements, ClinCraft provides real-time insights, predictive analytics, and user-friendly tools for researchers. It also promotes inclusivity by addressing demographic disparities in trial design. With its cutting-edge technology, ClinCraft is revolutionizing clinical research, accelerating approvals, and ultimately improving patient outcomes. Alessio De Simone, PhD, Matthew Apps, Robert Pelonzi, Bojana Palali?, Marko Jovovi?, Giovanni Bottegoni, Terence Smith #ClinicalTrials #AIinHealthcare #PharmaAI #DrugDevelopment #ClinicalResearch #TrialOptimization #HealthcareInnovation #RegulatoryCompliance #PatientInclusion #MedicalAdvancements #LifeSciences #Biotech #AIforGood #FutureofMedicine #ClinicalTrialTech

  • 查看Insight的组织主页

    2,586 位关注者

    WELCOMING OUR NEW SCIENTIFIC BOARD MEMBER - January 2025 Giovanni Bottegoni Assoc. Prof. of Medicinal Chemistry Prof. Giovanni Bottegoni is a leading expert in computational chemistry and drug discovery, currently an Associate Professor of Medicinal Chemistry at the University of Urbino. He earned his Ph.D. in Medicinal Chemistry from the Dipartimento di Chimica industriale - Università di Bologna and gained research experience at The Scripps Research Institute in the U.S. He has held key roles at the Istituto Italiano di Tecnologia (IIT) and Heptares Theraputics, and co-founded BiKi Technologies, specializing in computational drug discovery solutions. With over 50 published studies, four patents, and certifications from EPFL and MISB Bocconi School of Management, Prof. Bottegoni brings a wealth of expertise to Insight Scientific Board. IDM Insight

    • 该图片无替代文字
  • 查看Insight的组织主页

    2,586 位关注者

    ??? New Podcast Episode: Gut Feelings: Decoding the Microbiome ??? I’m thrilled to announce the latest episode of That’s a Load of Science! In this special episode, Alessio De Simone, PhD sits down with (Rose) Emilie Glad Bak, PhD, a distinguished microbiome researcher and thought leader, to explore one of the most fascinating areas of health and science: the microbiome. ???? Here’s what we dive into: ?? The microbiome and your health: Why the trillions of microbes in our bodies are key players in digestion, immunity, mental health, and beyond. ?? Latest research breakthroughs: From precision probiotics to microbiome-based therapies, Emilie unpacks how science is uncovering new ways to treat and prevent disease. ?? A paradigm shift in medicine: How a deeper understanding of the microbiome is shaping the future of personalized healthcare. ?? What’s next: The potential for microbiome science to redefine how we approach health and well-being over the next decade. Dr. Glad Bak also shares her journey into microbiome research, offering a behind-the-scenes look at the challenges and rewards of exploring this groundbreaking field. ?? Tune in to discover how the microbiome research is at the heart of the future medicine!

  • 查看Insight的组织主页

    2,586 位关注者

    January 2025: Driving Awareness for Health & Inclusion??? This January, Insight is proud to support three crucial health initiatives worldwide, each vital for transforming healthcare and improving patient outcomes. Cervical Health Awareness Month?? ???Cervical cancer, preventable yet deadly, claims over 300,000 lives annually. Achievements include WHO's strides in promoting HPV vaccinations and the rise of self-sampling HPV kits, improving global screening access. Challenges remain in healthcare equity and expanding educational campaigns about the importance of regular screenings. Support: National Cervical Cancer Coalition (https://lnkd.in/gUDPKpf), UK Cervical Cancer (https://lnkd.in/eXMvP64c). National Blood Donor Month? ???Blood shortages impact lives worldwide, emphasizing the need for regular donations. Successes include better awareness through WHO’s initiatives and safer, more accessible transfusions. Work is needed to mobilize donors, especially younger people, and enhance outreach in underserved areas. Help by locating a donation center via American Red Cross (https://lnkd.in/e3x4YwH) or NHS Blood and Transplant (https://www.blood.co.uk/). World Leprosy Day (January 28)?? ???Despite being curable, leprosy affects many, with significant stigma and treatment barriers. Progress has been made in free treatment access and stigma reduction through education. Continued efforts are needed for timely patient care and discrimination elimination. Support: The Leprosy Mission (https://lnkd.in/e-nQU98u). ???Join Insight in making an impact.??By supporting these causes, we can foster a healthier, more inclusive world. #CervicalHealth #BloodDonation #WorldLeprosyDay #HealthcareInnovation #PatientInclusion #Insight

    • 该图片无替代文字
  • 查看Insight的组织主页

    2,586 位关注者

    ??Explore how micro-level innovations drive macro-level transformations on "That's a Load of Science"! ??This time on our latest podcast, Insight's Chief Medical Officer Alessio De Simone, PhD., teams up with Christian Caprara, PhD., Project Manager at Novonesis, to delve into the revolutionary world of BioSolutions. From enhancing healthcare to advancing sustainable energy, these biological solutions harness nature's ingenuity to foster a sustainable and healthier future. ??At the forefront of scientific innovation, BioSolutions are reshaping industries by increasing efficiency, reducing environmental impacts, and paving the way for sustainable agricultural practices and cleaner energy solutions. They also play a crucial role in developing eco-friendly healthcare treatments that align with environmental sustainability goals. ??Tune in for an enlightening conversation on how cutting edge science is pivotal to our future. As we explore these transformative technologies, we also recognize the pivotal role that everyone plays in fighting climate change. Together, we can forge a path toward a brighter, more sustainable future for the next generations. Watch now and be inspired to contribute to impactful change! Spotify: https://lnkd.in/eBGXs5KC YouTube: https://lnkd.in/eE5WPJGB #BioSolutions??#SustainableInnovation #GreenTechnology #EcoFriendlyHealthcare #ClimateAction #ThatsaLoadofScience

    • 该图片无替代文字

相似主页

查看职位

融资